HONG KONG, Sept. 13, 2024 /PRNewswire/ — Innovative technology brand TECNO today unveiled the new PHANTOM V Fold2 5G – an AI-enhanced second-generation foldable smartphone that brings more efficiency for business professionals and creatives. Embracing the incredible possibilities of large screen foldable devices, it is a powerhouse of productivity and creativity elevated by futuristic AI innovation. […]
Category Archives: Pr Newswire
HONG KONG, Sept. 13, 2024 /PRNewswire/ — Innovative technology brand TECNO today unveiled its new AI-enhanced, second-generation flip smartphone, PHANTOM V Flip2 5G. A remarkable fusion of on-trend aesthetic design and powerful technologies, it brings stylish individuals a fun, fashionable and functional flip phone experience that makes every day iconic. Bringing pocket-sized ease and elegance to […]
RIYADH, Saudi Arabia, Sept. 13, 2024 /PRNewswire/ — The third edition of the Global AI Summit (GAIN) closed today, after a series high profile collaborations poised to drive AI innovation and growth. Hosted by the Saudi Data and AI Authority (SDAIA), GAIN has brought together AI experts and business leaders from across the globe. The […]
CARMEL, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the pricing of its initial public offering of 10,200,000 shares of its common stock at […]
FOSTER CITY, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the closing of its previously announced underwritten public offering of 14,064,048 shares of its common stock, […]
LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate in a Fireside Chat at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 10:55am ET / […]
CALGARY, Alberta, Sept. 12, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that it has refiled its management’s discussion and analysis (“MD&A”) for the financial year ended December […]
SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that on September 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 33,500 shares of its common stock. These […]
Acquisition will enable Actian, a division of HCLSoftware, to offer customers a complete data ecosystem SANTA CLARA, Calif., Sept. 13, 2024 /PRNewswire/ — HCLSoftware, the software business division of HCLTech, today announced that it completed the acquisition of Zeenea, an innovator in data catalog and governance solutions based in Paris, France. The acquisition of Zeenea enables […]
ANAHEIM, Calif., Sept. 13, 2024 /PRNewswire/ — EliTe Solar, a leading innovator in solar energy solutions, participated in RE+ 2024, one of North America’s largest renewable energy trade shows. The event took place from September 10-12, 2024, in Anaheim, California, where EliTe Solar unveiled its latest advancements in solar cell and module technology, designed to […]
